NCT04491903

REBOA for Out-of-hospital Cardiac Arrest

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: neurescue · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

Cardiac arrest is a major health problem that carries a high mortality rate. Substantial research and development have been put into changing the outcome of cardiac arrest and despite the advent of automated external defibrillators (AED), increase in bystander Cardiopulmonary resuscitation (CPR) and automated CPR devices (ACPR), the proportion of patient survival to hospital discharge has only minimally improved. The objective is to investigate safety and performance of the Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) procedure as an adjunct to Advanced Life Support (ALS) for treatment of refractory cardiac arrest.

Detailed description

The scope of the study is to collect data on patients with refractory out of hospital cardiac arrest (OHCA) for this feasibility study. Data collected: * from enrolment of the patient until hospital arrival * every 24 hours * at discharge or 7 days post enrollment * at 30 days post enrollment The investigation is initiated to investigate the safety and performance of the REBOA procedure for patients experiencing refractory OHCA.

Conditions

• Cardiac Arrest

Interventions

Type	Name	Description
PROCEDURE	REBOA	Endovascular balloon occlusion of the aorta

Timeline

• Start date: 2020-11-30
• Primary completion: 2020-11-30
• Completion: 2020-11-30
• First posted: 2020-07-30
• Last updated: 2021-05-04